Day: December 4, 2020

COMMUNICATION DES EXIGENCES PRUDENTIELLES DE CAPITAL APPLICABLES AU 1erJANVIER 2021Communiqué de presseParis, le 4 décembre 2020                              La Banque Centrale Européenne a notifié l’exigence de capital supplémentaire au titre du P2R  (Pillar 2 requirement) à partir du 1er janvier 2021. Cette dernière est inchangée et s’établit, pour Société Générale, à 1,75%.En tenant compte des différents coussins réglementaires ainsi que de la mise en œuvre anticipée de l’article 104A de la réglementation CRD5, les exigences minimales applicables à Société Générale sur base consolidée s’établissent respectivement à 9,03% pour le ratio CET1, 10,86% pour le ratio Tier 1 et 13,29% pour le ratio Total Capital.Avec un ratio CET1 du Groupe à 13,2%(1) au 30 septembre 2020, le Groupe bénéficie d’une marge confortable d’environ 420 points de...

DISCLOSURE OF REGULATORY CAPITAL REQUIREMENTS AS FROM 1 JANUARY 2021Press releaseParis, 4 December 2020The European Central Bank notified the level of additional requirement in respect of P2R (Pillar 2 Requirement) for Societe Generale, which will apply from 1 Janvier 2021. This level remains unchanged and will stand at 1.75% for Societe Generale.Taking into account the combined regulatory buffers as well as the early implementation of Article 104A of the CRD5 regulation, the minimum requirements applicable to Societe Generale on a consolidated basis are respectively 9.03% for the CET1 ratio, 10.86% for the Tier 1 ratio and 13.29% for the Total Capital ratio.With a CET1 ratio at 13.2% (1) as of 30 September 2020, the Group benefits from a comfortable buffer of almost 420 basis points above the threshold for triggering distribution limitations. (1) ...

– New Efficacy Data Describe Strong Evidence of Seizure Reduction over 12 Months of Treatment, Including a 73% Median Reduction from Baseline in Monthly Seizure Frequency at Month 12 –– Zygel™ Improves the Profound Sleep Disturbance Often Experienced by Developmental and Epileptic Encephalopathy (DEE) Patients Enrolled in the BELIEVE Trial –DEVON, Pa., Dec. 04, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters describing the efficacy, safety and quality of life results of the Phase 2 BELIEVE (Open Label Study to Assess the Safety and Efficacy of Zygel™ (ZYN002) Administered as a Transdermal Gel to Children and Adolescents with...

We can confirm that the dispute between Novaturas and GetJet Airlines regarding the fulfillment of contractual obligations has been referred to the court. Novaturas ability to book a regular number of flights during the pandemic this year was limited by force majeure, as state-imposed restrictions on entry and exit prevented certain destinations from operating at all. Novaturas, having referred the dispute to the court, hopes that the court will confirm this assessment of the situation and restore the balance of contractual obligations between the parties. The court has now accepted the lawsuit and will hear it soon.By order of Tuesday, December 1, the court ruled on the need to apply interim measures to suspend certain clauses of the contract pending a court decision. The court did not assess in any way whether Novaturas could be granted...

Galime patvirtinti, kad teismui yra perduotas tarp Novaturo ir GetJet Airlines kilęs ginčas dėl sutartinių įsipareigojimų vykdymo. Novaturo galimybė šiais metais užsakyti ne pandemijos sąlygomis įprastą skrydžių kiekį buvo apribota nenugalimos jėgos (force majeure) aplinkybių, nes dėl valstybių įvestų atvykimo ir išvykimo apribojimų, kelionės tam tikromis kryptimis apskritai negalėjo būti vykdomos. Novaturas, perdavęs ginčo sprendimą teismui, tikisi, kad teismas patvirtins tokį susidariusios situacijos vertinimą bei atstatys sutartinių prievolių pusiausvyrą tarp šalių. Teismas šiuo metu yra priėmęs ieškinį ir jį nagrinės artimiausiu metu.Antradienį, gruodžio 1 d., priimta nutartimi teismas sprendė, ar yra reikalinga iki teismo sprendimo priėmimo taikyti laikinąsias apsaugos priemones – sustabdyti tam tikrų sutarties punktų vykdymą. Teismas...

OMER, Israel, Dec. 04, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq, TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced the closing of an underwritten public offering of 7,098,491 American Depositary Shares (the “ADSs”). Each ADS was sold to the public at a price per ADS of $1.83. The gross proceeds to the Company from this offering are expected to be approximately $13 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.The Company has also granted the underwriter a 45-day option to purchase up to an additional 15% of the number of ADSs offered in the public offering to cover...

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) — PsyBio Therapeutics, Inc. (“PsyBio”) and Leo Acquisitions Corp. (NEX: LEQ.H) (“Leo” or the “Company”) are pleased to announce the closing of the previously announced brokered private placement (the “Financing”) of subscription receipts (the “Subscription Receipts”) of PsyBio Therapeutics Financing Inc. (“Finco”), a special purpose British Columbia company incorporated solely for the purpose of the Financing and wholly-owned by the Chief Executive Officer of PsyBio, at a price of CAD$0.35 per Subscription Receipt for aggregate gross proceeds of CAD$14,493,394, approximately three times the original CAD$5.0...

MIAMI, Dec. 04, 2020 (GLOBE NEWSWIRE) — ShiftPixy, Inc. (NASDAQ: PIXY), a Florida-based staffing enterprise that designs, manages, and sells access to a disruptive, revolutionary platform that facilitates employment in the rapidly growing Gig Economy, today announced that it will be attending the Benzinga Global Small Cap Conference on Tuesday, December 8th, with CEO and co-founder Scott Absher presenting at 3:15 PM ET. Please click here to register for the event and presentation.About ShiftPixyShiftPixy is a disruptive human capital services enterprise, revolutionizing employment in the Gig Economy by delivering a next-gen platform for workforce management that helps businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens and better connect with a ready-for-hire workforce. With expertise...